Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Recursion Pharmaceuticals Surpasses Third-Quarter Expectations, Announces Milestone with Roche - StocksToTrade
Recursion Pharmaceuticals Surpasses Third-Quarter Expectations, Announces Milestone with Roche StocksToTrade
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Yahoo Finance
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success Yahoo Finance
Roche’s fenebrutinib shows best-in-disease potential in MS - European Pharmaceutical Review
Roche’s fenebrutinib shows best-in-disease potential in MS European Pharmaceutical Review
Roche in ongoing discussions with US government over drug pricing, CEO says - Pharmaceutical Technology
Roche in ongoing discussions with US government over drug pricing, CEO says Pharmaceutical Technology
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page